Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response

29 May 2004

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer therapeutics and mechanisms
Share to Drug Transport and Resistance Mechanisms
Share to Ferroptosis and cancer prognosis

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 15262134
DOI: 10.1016/j.ygyno.2004.03.035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic responsePMID 15262134Read ↗

MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapySemantic proximity Read ↗

RNA Sequencing Analysis for the Identification of Genes Associated with Cisplatin Resistance in Ovarian CancerSemantic proximity Read ↗

The significance of microRNA genes expression in ovarian cancer cell lines resistant to cytotoxic drugsSemantic proximity Read ↗

Inhibition of P-glycoprotein expression and reversal of drug resistance of human hepatoma HepG2 cells by multidrug resistance gene (mdr1) antisense RNASemantic proximity Read ↗

Multidrug Resistance Gene-1 Is a Useful Predictor of Paclitaxel-Based Chemotherapy for Patients with Ovarian CancerSemantic proximity Read ↗

Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cellsSemantic proximity Read ↗

Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapySemantic proximity Read ↗

Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.Semantic proximity Read ↗

Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interferenceSemantic proximity Read ↗

Copper‐transporting P‐type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: Comparative analysis with expression of <i>MDR1</i>, <i>MRP1</i>, <i>MRP2</i>, <i>LRP</i> and <i>BCRP</i>Semantic proximity Read ↗

Alternative Splicing of the <b> <i>Multidrug Resistance Protein 1/ATP Binding Cassette Transporter Subfamily</i> </b> Gene in Ovarian Cancer Creates Functional Splice Variants and Is Associated with Increased Expression of the Splicing Factors PTB and SRp20Semantic proximity Read ↗

Association between single nucleotide polymorphisms of drug resistance-associated genes and response to chemotherapy in advanced ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.